Clifford Chance advises Sanofi and joint bookrunners on $3 billion SEC-registered bond offering

Clifford Chance advised Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., Natixis Securities Americas LLC and Sanofi in connection with Sanofi’s successful $3 billion bond offering registered with the U.S. Securities and Exchange Commission. The transaction comprised a $3 billion aggregate issuance divided into five tranches: two floating-rate tranches and three fixed-rate tranches, with maturities ranging from two to seven years. Barclays Capital Inc., BNP Paribas Securities Corp. and BofA Securities, Inc. acted as global coordinators and joint bookrunners, with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc. and Natixis Securities Americas LLC serving as additional joint bookrunners. Sanofi, a R&D-driven biopharmaceutical company listed on NASDAQ and Euronext and leveraging artificial intelligence in its operations, was the issuer. Clifford Chance represented Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., Natixis Securities Americas LLC and Sanofi with a team composed by: Olivier Plessis (lead); with key support from Jill Concannon, Trey Oxendine and Tara Kade in London; and Cédric Burford, Auriane Bijon and Baya Hariche in Paris. U.S. and French tax aspects were handled by Avrohom Gelber and Gil Shauly in New York, and Pierre Goyat and Hanene Zemir in Paris.

Clifford Chance advises Sanofi and joint bookrunners on $3 billion SEC-registered bond offering

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads